Note: Ingredients listed on restricted chemical lists
EC/CAS
58-55-9
Name of the chemical
Theophyllin; 1,3-Dimethyl-3,7-dihydro-1H-purin-2,6-dion (2022/692)
Concentration
N/A
EC/CAS
77-93-0
Name of the chemical
citric acid, triethyl ester
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2021-11-19
Product name
THEOVENT TABLETS 300
Product Synonyms
THEOVENT TABLETS 300 MG * THEOVENT 300 PROLONGATUM TABLETKI 300 MG *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 3
Environmental hazards
Not classified. OSHA defined hazards Not classified.
Signal word
Danger
Hazard statements
Toxic if swallowed.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
Response
If swallowed: Immediately call a poison center/doctor/. Rinse mouth. Specific treatment (see this label).
Storage
Store locked up.
Disposal
Not available. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
32.59% of the mixture consists of component(s) of unknown acute oral toxicity. 37.59% of the mixture consists of component(s) of unknown acute dermal toxicity. 32.03% of the mixture consists of component(s) of unknown acute inhalation toxicity. 38.68% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 38.68% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
